Trading rund um Wachstumswerte

So, EPAM und SYNH morgen vor Eroeffnung mit ihren Zahlen..somit duerfte die Eroeffnung zumindest mal bei den zwei mit Bewegung verbunden sein

Wir werden sehen

*****

Epam (EPAM) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
----
https://www.zacks.com/stock/news/764247/...e_9-764247
*****

[b]Zacks Consensus Estimate[/b]

This clinical research company is expected to post quarterly earnings of $1.01 per share in its upcoming report, which represents a year-over-year change of +6.3%.
Revenues are expected to be $1.19 billion, up 4.1% from the year-ago quarter.
----
https://www.zacks.com/stock/quote/SYNH?q=SYNH

****